Litcius/Paper detail

Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria

Laurent Dortet, Claudia Niccolai, Niels Pfennigwerth, Stefanie Frisch, Camille Gonzalez, Alberto Antonelli, Tommaso Giani, Robert Hoenings, Soeren G. Gatermann, Gian María Rossolini, Thierry Naas

2023Journal of Antimicrobial Chemotherapy28 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Cefiderocol is a catechol-substituted cephalosporin with potent in vitro activity against carbapenem-resistant (CR) Gram-negative bacteria (GNB). Cefiderocol susceptibility testing is complex because iron concentrations need to be taken into consideration. Here, we assessed the clinical performance of Bruker's UMIC® Cefiderocol and corresponding iron-depleted CAMHB to determine MIC by broth microdilution (BMD) for clinically relevant GNB. METHODS: MICs of cefiderocol for 283 GN clinical isolates were determined by BMD using iron-depleted CAMHB. Frozen panels were used as a reference. The concentration range of cefiderocol was 0.03-32 mg/L. The isolates, with different degrees of susceptibility to cefiderocol, included Enterobacterales (n = 180), Pseudomonas aeruginosa (n = 49), Acinetobacter baumannii (n = 44) and Stenotrophomonas maltophilia (n = 10). RESULTS: The rates of categorical agreement (CA), essential agreement (EA) and bias were calculated to evaluate the performance of the UMIC® Cefiderocol, as compared with the reference method. Overall, the UMIC® Cefiderocol showed 90.8% EA (95% CI: 86.9%-93.7%) with a bias of -14.5% and a CA of 90.1% (95% CI: 86.1%-93.1%). For Enterobacterales, the UMIC® Cefiderocol showed 91.7% EA (95% CI: 86.7%-94.9%) with a bias of -25.0% and a CA of 87.8% (95% CI: 82.2%-91.8%). For non-fermenters, the UMIC® Cefiderocol showed 89.3% EA (95% CI: 81.9%-93.9%) (not significantly different from 90.0%, Student t-test) with a bias of -3.9% and a CA of 94.2% (95% CI: 87.7%-97.3%). CONCLUSIONS: UMIC® Cefiderocol is a valid method for the determination of cefiderocol MICs even if higher than expected discrepancies were observed with NDM-producing Enterobacterales, which presented in most cases MIC values close to the breakpoint.

Topics & Concepts

Acinetobacter baumanniiStenotrophomonas maltophiliaCephalosporinPseudomonas aeruginosaBiologyMicrobiologySiderophoreAcinetobacterBroth microdilutionBacteriaMinimum inhibitory concentrationAntimicrobialAntibioticsGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICU
Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria | Litcius